These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 26276451)
1. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective. Rosenbloom AL Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451 [TBL] [Abstract][Full Text] [Related]
2. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states. Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847 [TBL] [Abstract][Full Text] [Related]
3. Genetic defects of the growth-hormone-IGF axis associated with growth hormone insensitivity. Woods K Endocr Dev; 2007; 11():6-15. PubMed ID: 17986822 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations. Fang P; Girgis R; Little BM; Pratt KL; Guevara-Aguirre J; Hwa V; Rosenfeld RG J Clin Endocrinol Metab; 2008 Mar; 93(3):1030-7. PubMed ID: 18073295 [TBL] [Abstract][Full Text] [Related]
5. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment. Laron Z; Kauli R Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options. Kemp SF BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167 [TBL] [Abstract][Full Text] [Related]
7. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome. Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660 [TBL] [Abstract][Full Text] [Related]
8. A novel exonic GHR splicing mutation (c.784G > C) in a patient with classical growth hormone insensitivity syndrome. Akıncı A; Rosenfeld RG; Hwa V Horm Res Paediatr; 2013; 79(1):32-8. PubMed ID: 23006617 [TBL] [Abstract][Full Text] [Related]
9. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects. Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382 [TBL] [Abstract][Full Text] [Related]
10. Atypical defects resulting in growth hormone insensitivity. Wit JM; de Luca F Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721 [TBL] [Abstract][Full Text] [Related]
12. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ; Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic advances in growth hormone insensitivity. David A; Metherell LA; Clark AJ; Camacho-Hübner C; Savage MO Endocrinol Metab Clin North Am; 2005 Sep; 34(3):581-95, viii. PubMed ID: 16085161 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay. Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696 [TBL] [Abstract][Full Text] [Related]
15. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I. Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808 [TBL] [Abstract][Full Text] [Related]
16. Laron syndrome - A historical perspective. Laron Z; Werner H Rev Endocr Metab Disord; 2021 Mar; 22(1):31-41. PubMed ID: 32964395 [TBL] [Abstract][Full Text] [Related]
17. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I. Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718 [TBL] [Abstract][Full Text] [Related]
18. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322 [TBL] [Abstract][Full Text] [Related]
19. The History of the Insulin-Like Growth Factor System. Miller BS; Rogol AD; Rosenfeld RG Horm Res Paediatr; 2022; 95(6):619-630. PubMed ID: 36446332 [TBL] [Abstract][Full Text] [Related]
20. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family. Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]